Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insider trades were noted in Asana, Inc. (ASAN), Cosmos Health Inc. (COSM), and iTeos Therapeutics, Inc. (ITOS). ASAN's President, CEO, and Chair acquired 283,204 shares at an average price of $18.07, costing around $5.12 million. COSM's CEO acquired 6,712 shares at an average price of $23.66, costing around $158,806. ITOS's CFO bought 5,000 shares at an average price of $8.37, costing around $41,850.
October 13, 2023 | 11:34 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Asana's CEO acquired 283,204 shares, indicating confidence in the company. UBS initiated coverage on Asana with a Neutral rating and a price target of $20.
Insider trading often signals confidence in the company's prospects. The CEO's large purchase, along with UBS's neutral rating, could positively impact ASAN's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cosmos Health's CEO acquired 6,712 shares, indicating confidence in the company. Cosmos Health also announced a purchase agreement to acquire Cloudscreen.
The CEO's purchase of shares, along with the announcement of a strategic acquisition, could positively impact COSM's stock in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
iTeos Therapeutics' CFO bought 5,000 shares, indicating confidence in the company despite a reported loss for the second quarter.
The CFO's purchase of shares signals confidence in the company's future prospects. However, the recent Q2 loss may neutralize any short-term positive impact on ITOS's stock.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100